What does BIOTETRA do?

BIOTETRA is a wholesaler in Gent. Public Limited, started on 1 November 1987, 1 establishment.

What is the address of BIOTETRA?

The registered office of BIOTETRA is located at Vaderlandstraat 48, 9000 Gent.

Is BIOTETRA still active?

Yes. According to the CBE (30 October 2026) BIOTETRA is active, legal situation “Normale toestand”, started on 1 November 1987.

Is BIOTETRA registered on Peppol?

Yes, BIOTETRA is registered on the Peppol network with ID 0208:0432356714.

What is the enterprise number of BIOTETRA?

The enterprise number of BIOTETRA is BE0432356714.

When was BIOTETRA founded?

BIOTETRA was founded on 1 November 1987.

Who are the directors of BIOTETRA?

According to the 2025 annual accounts, the directors of BIOTETRA are: Steven DESMYTER, Stefan DESMYTER, Stefanie DESMYTER.

Is BIOTETRA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 November 1987; 4 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did BIOTETRA make in 2025?

BIOTETRA posted a profit after taxes of € 1,985 in financial year 2025.

What is the revenue of BIOTETRA?

As a small company, BIOTETRA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -13,679.

BIOTETRA (Public Limited) - Gent - BE0432356714

Dossier BIOTETRA, printed on 30 October 2026 from databakkes.be/en/0432356714/biotetra. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 46 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

BIOTETRA from Gent, company number BE0432356714, closed financial year 2025 with a result of € 1,985 after tax. For that financial year BIOTETRA recorded a gross margin of € -13,679 and equity of € 211,749. Compared with financial year 2024, the result moved from € -371 to € 1,985. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 15, 2026.

What it is worth Growing

€ 211,749

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1,985

▲ still € 371 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 473,548

▲ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 150,249.

People and assets in 2025

Vehicles and equipment

€ 214

▼ 63% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,612

▼ 15% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -4,839 Gross margin 2022: € -4,839 First fiscal year in the series	€ -5,383 Gross margin 2023: € -5,383 ▼ € 545 vs 2022 (€ -4,839) Unfavourable step	€ -11,086 Gross margin 2024: € -11,086 ▼ € 5,703 vs 2023 (€ -5,383) Unfavourable step	€ -13,679 Gross margin 2025: € -13,679 ▼ € 2,592 vs 2024 (€ -11,086) Unfavourable step	▼ € 2,592
Profit after taxes	€ 116 Profit after taxes 2022: € 116 First fiscal year in the series	€ -9,473 Profit after taxes 2023: € -9,473 ▼ € 9,589 vs 2022 (€ 116) Unfavourable step	€ -371 Profit after taxes 2024: € -371 ▲ € 9,102 vs 2023 (€ -9,473) Favourable step	€ 1,985 Profit after taxes 2025: € 1,985 ▲ € 2,356 vs 2024 (€ -371) Favourable step	▲ € 2,356
Equity	€ 219,608 Equity 2022: € 219,608 First fiscal year in the series	€ 210,136 Equity 2023: € 210,136 ▼ 4% vs 2022 (€ 219,608) Unfavourable step	€ 209,764 Equity 2024: € 209,764 Unchanged (€ 210,136) Unfavourable step	€ 211,749 Equity 2025: € 211,749 ▲ 1% vs 2024 (€ 209,764) Favourable step	▲ 1%
Total debts	€ 2,207,883 Total debts 2022: € 2,207,883 First fiscal year in the series	€ 1,954,582 Total debts 2023: € 1,954,582 ▼ 11% vs 2022 (€ 2,207,883) Favourable step	€ 1,934,428 Total debts 2024: € 1,934,428 ▼ 1% vs 2023 (€ 1,954,582) Favourable step	€ 1,432,969 Total debts 2025: € 1,432,969 ▼ 26% vs 2024 (€ 1,934,428) Favourable step	▼ 26%
Cash	€ 1,323,546 Cash 2022: € 1,323,546 First fiscal year in the series	€ 1,161,635 Cash 2023: € 1,161,635 ▼ 12% vs 2022 (€ 1,323,546) Unfavourable step	€ 286,741 Cash 2024: € 286,741 ▼ 75% vs 2023 (€ 1,161,635) Unfavourable step	€ 473,548 Cash 2025: € 473,548 ▲ 65% vs 2024 (€ 286,741) Favourable step	▲ 65%
Land & buildings	€ 86,184 Land & buildings 2022: € 86,184 First fiscal year in the series	€ 81,877 Land & buildings 2023: € 81,877 ▼ 5% vs 2022 (€ 86,184) Unchanged	€ 77,811 Land & buildings 2024: € 77,811 ▼ 5% vs 2023 (€ 81,877) Unchanged	€ 77,811 Land & buildings 2025: € 77,811 Unchanged (€ 77,811) Unchanged
Retained profit	€ 158,108 Retained profit 2022: € 158,108 First fiscal year in the series	€ 148,636 Retained profit 2023: € 148,636 ▼ 6% vs 2022 (€ 158,108) Unfavourable step	€ 148,264 Retained profit 2024: € 148,264 Unchanged (€ 148,636) Unfavourable step	€ 150,249 Retained profit 2025: € 150,249 ▲ 1% vs 2024 (€ 148,264) Favourable step	▲ 1%
Balance sheet total	€ 2,427,491 Balance sheet total 2022: € 2,427,491 First fiscal year in the series	€ 2,164,718 Balance sheet total 2023: € 2,164,718 ▼ 11% vs 2022 (€ 2,427,491) Unchanged	€ 2,144,192 Balance sheet total 2024: € 2,144,192 ▼ 1% vs 2023 (€ 2,164,718) Unchanged	€ 1,644,718 Balance sheet total 2025: € 1,644,718 ▼ 23% vs 2024 (€ 2,144,192) Unchanged	▼ 23%

Key figures of BIOTETRA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to BIOTETRA?

What happened at BIOTETRA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 15, 2026 New annual accounts for financial year 2025: profit of € 1,985. Source: NBB ↗
Nov 19, 1987 New establishment in Gent. KBO
Nov 1, 1987 Start of the company according to the CBE. KBO

In short

From € 116 profit in 2022 to € 1,985 profit in 2025.

Paid € 4,996 in corporate taxes since 2022.

Best year ever: 2025, with € 1,985 profit.

Original PDFs at the National Bank ↗

Management

Steven DESMYTER Stefan DESMYTER Stefanie DESMYTER

BIOTETRA

Dr. Baransu

Behind BIOTETRA are Steven DESMYTER, Stefan DESMYTER and Stefanie DESMYTER. Stefanie DESMYTER is also behind Dr. Baransu.

Directors

According to the 2025 annual accounts

Steven DESMYTER

Managing director

Stefan DESMYTER

Managing director

Stefanie DESMYTER

Managing director

Also active at: Dr. Baransu

Establishments

Establishment units

Physical locations of this company

Registered office

Vaderlandstraat 48

9000 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0432.356.714
VAT number: BE 0432.356.714
Registered office: Vaderlandstraat 48, 9000 Gent
Names & denominations: BIOTETRA
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 1 November 1987
Peppol: Active · Active since 7 May 2026
Activities · NACE: Groothandel in andere voedingsmiddelen, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOTETRA

Warning lights

Financials

What happened to BIOTETRA?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions